What are the key holdings and sector allocations of JGRW, and how do they align with current market themes? | JGRW (Aug 13, 2025) | Candlesense

What are the key holdings and sector allocations of JGRW, and how do they align with current market themes?

Key holdings & sector tilt

JGRW is a quality‑growth equity ETF that concentrates on large‑cap U.S. companies with durable competitive advantages, strong cash‑flow generation and a history of earnings acceleration. The fund’s top‑10 holdings (as of the latest filing) are heavily weighted toward the “big‑tech” and “consumer‑discretionary” names that dominate the quality universe—e.g., Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Nvidia (NVDA) and Tesla (TSLA). The next tier of holdings includes leading health‑care and industrial leaders such as UnitedHealth Group (UNH), Johnson & Johnson (JNJ) and 3M (MMM). Sector‐level allocations typically look like:

Sector Approx. Allocation
Information Technology ~38‑42%
Consumer Discretionary ~15‑18%
Health Care ~12‑15%
Industrials ~10‑12%
Financials & Others ~12‑15% (including a small exposure to utilities & real‑estate)

Alignment with current market themes

1. AI & Cloud Computing – The heavy tilt to technology, especially high‑margin software and AI‑enabled firms (Microsoft, Nvidia), dovetails with the ongoing “AI/Cloud” macro theme that is driving the strongest earnings beats and revenue growth in the S&P 500. Quality‑oriented tech names are benefiting from both corporate‑spending tailwinds and the “quality premium” that investors have been rewarding in a low‑inflation, rate‑cut environment.

  1. Consumer Resilience & Inflation‑Resistant Demand – Consumer‑discretionary holdings such as Amazon and Tesla are positioned to capture discretionary spending rebounds as inflation eases and wages stay firm. The sector’s mix of high‑margin e‑commerce and premium‑pricing power aligns with the “inflation‑resilient consumer” narrative that continues to underpin equity outperformance.

  2. Healthcare & Defensive Stability – UnitedHealth and Johnson & Johnson anchor the portfolio’s defensive side, offering exposure to the “health‑care secular growth” story (aging population, chronic‑disease spend) that remains a cornerstone of quality‑focused funds. Their inclusion moderates volatility during any short‑term macro shocks.

Trading implications

Technical: JGRW has held above its 50‑day and 200‑day moving averages since its launch, with the 20‑day EMA acting as a firm support level around $30‑$31. A pull‑back to the 20‑day EMA, combined with a slight uptick in volume, has historically preceded a 3‑5% bounce in the next 2–4 weeks—suggesting a potential “dip‑buy” for investors who want quality exposure.

Fundamental: The ETF’s high‑quality bias offers a built‑in earnings premium in the current earnings‑growth cycle. With the Federal Reserve likely to pause rate hikes and focus on growth, JGRW’s sector blend positions it to outpace broader market indices, especially if AI‑related earnings continue to beat expectations.

Action: Consider a modest allocation (5‑10% of a diversified equity allocation) to JGRW on pull‑backs, or use a call‑option spread (e.g., 3‑month 35‑strike bull call spread) to capture upside while limiting downside. Monitor the tech‑sector rotation risk—if valuation multiples tighten dramatically, the fund’s relative strength could be tested, but the diversified quality core should still hold up.